Results for tag: "Viral Antigen"

The Viral Antigen market is a subset of the Infectious Diseases Drugs market, which focuses on the development of treatments for viral infections. Viral antigens are molecules that are recognized by the immune system and can be used to diagnose and treat viral infections. These antigens can be used to create vaccines, which are used to prevent viral infections, or to create treatments that can be used to treat existing infections. Viral antigens can also be used to create diagnostic tests, which are used to detect the presence of a virus in a patient. The Viral Antigen market is a rapidly growing field, with many companies investing in research and development to create new treatments and diagnostic tests. Companies in this market include GlaxoSmithKline, Merck, Pfizer, Sanofi, and Johnson & Johnson. Show Less Read more